Roger Song Score: 21
Analyst at
Jefferies
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-0.9%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
47%
18 W / 20 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
38%
10 W / 16 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 26 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 26 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
50%
17 W / 17 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
46%
16 W / 19 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
67%
2 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 08, 2026 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$45.00
Est. +189%
|
$15.56 | $25.15 |
Pending
|
$23.60
+51.7%
|
| Apr 28, 2026 |
Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
KNSA
|
BUY |
$71.00
Est. +32%
|
$53.80 | $82.94 |
Target Met
|
$80.92
+50.4%
|
| Mar 18, 2026 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$16.00
Est. +247%
|
$4.61 | $5.31 |
Pending
|
$3.17
-31.2%
|
| Mar 18, 2026 |
Protagonist Therapeutics Inc
PTGX
|
BUY |
$121.00
Est. +24%
|
$97.78 | $141.10 |
Target Met
|
$133.00
+36.0%
|
| Mar 12, 2026 |
Viking Therapeutics Inc
VKTX
|
BUY |
$101.00
Est. +185%
|
$35.47 | $42.79 |
Pending
|
$33.43
-5.8%
|
| Mar 02, 2026 |
Veradermics, Incorporated
MANE
|
BUY |
$75.00
Est. +64%
|
$45.85 | $131.24 |
Target Met
|
$107.76
+135.0%
|
| Feb 18, 2026 |
BioAge Labs, Inc.
BIOA
|
BUY |
$62.00
Est. +216%
|
$19.63 | $25.96 |
Pending
|
$22.19
+13.0%
|
| Feb 17, 2026 |
Krystal Biotech Inc
KRYS
|
BUY |
$371.00
Est. +27%
|
$291.10 | $382.54 |
Target Met
|
$363.28
+24.8%
|
| Jan 22, 2026 |
Corvus Pharmaceuticals Inc
CRVS
|
BUY |
$42.00
Est. +63%
|
$25.80 | $26.95 |
Pending
|
$13.04
-49.5%
|
| Jan 06, 2026 |
Zenas BioPharma, Inc.
ZBIO
|
BUY |
$48.00
Est. +189%
|
$16.61 | $34.03 |
Pending
|
$31.09
+87.2%
|
| Nov 24, 2025 |
Nektar Therapeutics
NKTR
|
BUY |
$121.00
Est. +123%
|
$54.28 | $109.00 |
Pending
|
$70.68
+30.2%
|
| Oct 27, 2025 |
Zenas BioPharma, Inc.
ZBIO
|
BUY |
$52.00
Est. +64%
|
$31.80 | $44.60 |
Pending
|
$31.09
-2.2%
|
| Oct 10, 2025 |
Gyre Therapeutics Inc
GYRE
|
BUY |
$16.00
Est. +124%
|
$7.15 | $9.42 |
Pending
|
$5.64
-21.1%
|
| Sep 18, 2025 |
Nektar Therapeutics
NKTR
|
BUY |
$99.00
Est. +69%
|
$58.74 | $109.00 |
Target Met
|
$70.68
+20.3%
|
| Sep 02, 2025 |
United Therapeutics Corp
UTHR
|
BUY |
$564.00
Est. +39%
|
$404.81 | $609.35 |
Target Met
|
$524.70
+29.6%
|
| Aug 22, 2025 |
Atyr Pharma Inc
ATYR
|
BUY |
$17.00
Est. +218%
|
$5.35 | $6.50 |
Pending
|
$0.48
-91.0%
|
| Jun 12, 2025 |
CureVac N.V.
CVAC
|
SELL |
$5.00
Est. +11%
|
$5.60 | $4.00 (Low) |
Target Met
|
$4.66
+16.8%
|
| Dec 09, 2024 |
BioAge Labs, Inc.
BIOA
|
BUY |
$7.00
Est. +51%
|
$4.65 | $12.28 |
Target Met
|
$22.19
+377.2%
|
| Dec 03, 2024 |
Replimune Group Inc
REPL
|
BUY |
$19.00
Est. +31%
|
$14.48 | $14.80 |
Miss
|
$5.41
-62.6%
|
| Nov 19, 2024 |
Aclaris Therapeutics Inc
ACRS
|
BUY |
$7.00
Est. +123%
|
$3.14 | $5.17 |
Miss
|
$5.12
+63.1%
|
| Nov 13, 2024 |
Corvus Pharmaceuticals Inc
CRVS
|
BUY |
$13.00
Est. +227%
|
$3.97 | $10.00 |
Miss
|
$13.04
+228.5%
|
| Nov 06, 2024 |
Vaxcyte Inc
PCVX
|
BUY |
$146.00
Est. +37%
|
$106.74 | $116.00 |
Miss
|
$52.98
-50.4%
|
| Nov 04, 2024 |
Viking Therapeutics Inc
VKTX
|
BUY |
$110.00
Est. +74%
|
$63.14 | $79.10 |
Miss
|
$33.43
-47.1%
|
| Oct 23, 2024 |
Disc Medicine Inc
IRON
|
BUY |
$89.00
Est. +75%
|
$50.92 | $95.95 |
Target Met
|
$73.67
+44.7%
|
| Oct 21, 2024 |
BioAge Labs, Inc.
BIOA
|
BUY |
$42.00
Est. +76%
|
$23.86 | $6.00 |
Miss
|
$22.19
-7.0%
|
| Oct 16, 2024 |
Novavax, Inc.
NVAX
|
BUY |
$25.00
Est. +146%
|
$10.15 | $11.50 |
Miss
|
$7.34
-27.7%
|
| Oct 11, 2024 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$41.00
Est. +78%
|
$23.04 | $29.56 |
Miss
|
$23.60
+2.4%
|
| Oct 08, 2024 |
Zenas BioPharma, Inc.
ZBIO
|
BUY |
$35.00
Est. +87%
|
$18.70 | $26.57 |
Miss
|
$31.09
+66.3%
|
| Sep 13, 2024 |
Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
KNSA
|
BUY |
$40.00
Est. +63%
|
$24.49 | $37.33 |
Miss
|
$80.92
+230.4%
|
| Sep 03, 2024 |
Vaxcyte Inc
PCVX
|
BUY |
$129.00
Est. +16%
|
$111.13 | $121.06 |
Miss
|
$52.98
-52.3%
|
| Aug 21, 2024 |
Aadi Bioscience Inc
AADI
|
SELL |
$1.50
Est. +3%
|
$1.55 | $1.40 (Low) |
Target Met
|
$2.05
-32.3%
|
| Jul 19, 2024 |
Novavax, Inc.
NVAX
|
BUY |
$31.00
Est. +116%
|
$14.36 | $17.81 |
Miss
|
$7.34
-48.9%
|
| May 05, 2024 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$8.00
Est. +79%
|
$4.46 | $1.52 |
Miss
|
$3.17
-28.9%
|
| Apr 17, 2024 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$97.00
Est. +50%
|
$64.75 | $113.51 |
Target Met
|
$123.96
+91.4%
|
| Mar 20, 2024 |
LAVA Therapeutics NV
LVTX
|
BUY |
$6.00
Est. +95%
|
$3.07 | $2.39 |
Miss
|
$1.74
-43.3%
|
| Mar 20, 2024 |
Tourmaline Bio Inc
TRML
|
BUY |
$72.00
Est. +61%
|
$44.67 | $29.79 |
Miss
|
$47.98
+7.4%
|
| Mar 12, 2024 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$2.50
Est. +16%
|
$2.15 | $1.52 |
Miss
|
$3.17
+47.4%
|
| Apr 05, 2022 |
Finch Therapeutics Group Inc
FNCH
|
SELL |
$17.00
Est. +100%
|
$4,428.00 | - | - |
$9.60
+99.8%
|
Nurix Therapeutics Inc
NRIX
Jun 08, 2026
Signal & Target
BUY
$45.00
Start Price
$15.56
Best Price (1Y)
$25.15
Current Price
$23.60
Return
+51.7%
Signal & Target
BUY
$71.00
Start Price
$53.80
Best Price (1Y)
$82.94
Current Price
$80.92
Return
+50.4%
CytomX Therapeutics Inc
CTMX
Mar 18, 2026
Signal & Target
BUY
$16.00
Start Price
$4.61
Best Price (1Y)
$5.31
Current Price
$3.17
Return
-31.2%
Protagonist Therapeutics Inc
PTGX
Mar 18, 2026
Signal & Target
BUY
$121.00
Start Price
$97.78
Best Price (1Y)
$141.10
Current Price
$133.00
Return
+36.0%
Viking Therapeutics Inc
VKTX
Mar 12, 2026
Signal & Target
BUY
$101.00
Start Price
$35.47
Best Price (1Y)
$42.79
Current Price
$33.43
Return
-5.8%
Veradermics, Incorporated
MANE
Mar 02, 2026
Signal & Target
BUY
$75.00
Start Price
$45.85
Best Price (1Y)
$131.24
Current Price
$107.76
Return
+135.0%
BioAge Labs, Inc.
BIOA
Feb 18, 2026
Signal & Target
BUY
$62.00
Start Price
$19.63
Best Price (1Y)
$25.96
Current Price
$22.19
Return
+13.0%
Krystal Biotech Inc
KRYS
Feb 17, 2026
Signal & Target
BUY
$371.00
Start Price
$291.10
Best Price (1Y)
$382.54
Current Price
$363.28
Return
+24.8%
Corvus Pharmaceuticals Inc
CRVS
Jan 22, 2026
Signal & Target
BUY
$42.00
Start Price
$25.80
Best Price (1Y)
$26.95
Current Price
$13.04
Return
-49.5%
Zenas BioPharma, Inc.
ZBIO
Jan 06, 2026
Signal & Target
BUY
$48.00
Start Price
$16.61
Best Price (1Y)
$34.03
Current Price
$31.09
Return
+87.2%
Nektar Therapeutics
NKTR
Nov 24, 2025
Signal & Target
BUY
$121.00
Start Price
$54.28
Best Price (1Y)
$109.00
Current Price
$70.68
Return
+30.2%
Zenas BioPharma, Inc.
ZBIO
Oct 27, 2025
Signal & Target
BUY
$52.00
Start Price
$31.80
Best Price (1Y)
$44.60
Current Price
$31.09
Return
-2.2%
Gyre Therapeutics Inc
GYRE
Oct 10, 2025
Signal & Target
BUY
$16.00
Start Price
$7.15
Best Price (1Y)
$9.42
Current Price
$5.64
Return
-21.1%
Nektar Therapeutics
NKTR
Sep 18, 2025
Signal & Target
BUY
$99.00
Start Price
$58.74
Best Price (1Y)
$109.00
Current Price
$70.68
Return
+20.3%
United Therapeutics Corp
UTHR
Sep 02, 2025
Signal & Target
BUY
$564.00
Start Price
$404.81
Best Price (1Y)
$609.35
Current Price
$524.70
Return
+29.6%
Atyr Pharma Inc
ATYR
Aug 22, 2025
Signal & Target
BUY
$17.00
Start Price
$5.35
Best Price (1Y)
$6.50
Current Price
$0.48
Return
-91.0%
CureVac N.V.
CVAC
Jun 12, 2025
Signal & Target
SELL
$5.00
Start Price
$5.60
Best Price (1Y)
$4.00
Current Price
$4.66
Return
+16.8%
BioAge Labs, Inc.
BIOA
Dec 09, 2024
Signal & Target
BUY
$7.00
Start Price
$4.65
Best Price (1Y)
$12.28
Current Price
$22.19
Return
+377.2%
Replimune Group Inc
REPL
Dec 03, 2024
Signal & Target
BUY
$19.00
Start Price
$14.48
Best Price (1Y)
$14.80
Current Price
$5.41
Return
-62.6%
Aclaris Therapeutics Inc
ACRS
Nov 19, 2024
Signal & Target
BUY
$7.00
Start Price
$3.14
Best Price (1Y)
$5.17
Current Price
$5.12
Return
+63.1%
Corvus Pharmaceuticals Inc
CRVS
Nov 13, 2024
Signal & Target
BUY
$13.00
Start Price
$3.97
Best Price (1Y)
$10.00
Current Price
$13.04
Return
+228.5%
Vaxcyte Inc
PCVX
Nov 06, 2024
Signal & Target
BUY
$146.00
Start Price
$106.74
Best Price (1Y)
$116.00
Current Price
$52.98
Return
-50.4%
Viking Therapeutics Inc
VKTX
Nov 04, 2024
Signal & Target
BUY
$110.00
Start Price
$63.14
Best Price (1Y)
$79.10
Current Price
$33.43
Return
-47.1%
Disc Medicine Inc
IRON
Oct 23, 2024
Signal & Target
BUY
$89.00
Start Price
$50.92
Best Price (1Y)
$95.95
Current Price
$73.67
Return
+44.7%
BioAge Labs, Inc.
BIOA
Oct 21, 2024
Signal & Target
BUY
$42.00
Start Price
$23.86
Best Price (1Y)
$6.00
Current Price
$22.19
Return
-7.0%
Novavax, Inc.
NVAX
Oct 16, 2024
Signal & Target
BUY
$25.00
Start Price
$10.15
Best Price (1Y)
$11.50
Current Price
$7.34
Return
-27.7%
Nurix Therapeutics Inc
NRIX
Oct 11, 2024
Signal & Target
BUY
$41.00
Start Price
$23.04
Best Price (1Y)
$29.56
Current Price
$23.60
Return
+2.4%
Zenas BioPharma, Inc.
ZBIO
Oct 08, 2024
Signal & Target
BUY
$35.00
Start Price
$18.70
Best Price (1Y)
$26.57
Current Price
$31.09
Return
+66.3%
Signal & Target
BUY
$40.00
Start Price
$24.49
Best Price (1Y)
$37.33
Current Price
$80.92
Return
+230.4%
Vaxcyte Inc
PCVX
Sep 03, 2024
Signal & Target
BUY
$129.00
Start Price
$111.13
Best Price (1Y)
$121.06
Current Price
$52.98
Return
-52.3%
Aadi Bioscience Inc
AADI
Aug 21, 2024
Signal & Target
SELL
$1.50
Start Price
$1.55
Best Price (1Y)
$1.40
Current Price
$2.05
Return
-32.3%
Novavax, Inc.
NVAX
Jul 19, 2024
Signal & Target
BUY
$31.00
Start Price
$14.36
Best Price (1Y)
$17.81
Current Price
$7.34
Return
-48.9%
CytomX Therapeutics Inc
CTMX
May 05, 2024
Signal & Target
BUY
$8.00
Start Price
$4.46
Best Price (1Y)
$1.52
Current Price
$3.17
Return
-28.9%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Apr 17, 2024
Signal & Target
BUY
$97.00
Start Price
$64.75
Best Price (1Y)
$113.51
Current Price
$123.96
Return
+91.4%
LAVA Therapeutics NV
LVTX
Mar 20, 2024
Signal & Target
BUY
$6.00
Start Price
$3.07
Best Price (1Y)
$2.39
Current Price
$1.74
Return
-43.3%
Tourmaline Bio Inc
TRML
Mar 20, 2024
Signal & Target
BUY
$72.00
Start Price
$44.67
Best Price (1Y)
$29.79
Current Price
$47.98
Return
+7.4%
CytomX Therapeutics Inc
CTMX
Mar 12, 2024
Signal & Target
BUY
$2.50
Start Price
$2.15
Best Price (1Y)
$1.52
Current Price
$3.17
Return
+47.4%
Finch Therapeutics Group Inc
FNCH
Apr 05, 2022
Signal & Target
SELL
$17.00
Start Price
$4,428.00
Best Price (1Y)
-
Current Price
$9.60
Return
+99.8%